FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.

doi:10.1371/journal.pone.0074543

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.

PloS one - 1 Jan 2013

Xu Lei, Zhou Xin, Jiang Feng, Qiu Man-Tang, Zhang Zhi, Yin Rong, Xu Lin

Abstract excerpt

BACKGROUND: Published studies investigating the association between genetic polymorphism -884C/T (rs763110) of the FAS ligand (FASL) promoter and cancer risk reported inconclusive results. To derive a more precise estimation of the relationship, we performed an updated meta-analysis of all eligible studies. METHODOLOGY/PRINCIPAL FINDINGS: We carried out a meta-analysis, including 47 studies with 19,810 cases and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fas Ligand Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Heterogeneity

Share to Heterozygote

Share to Neoplasms

Share to Odds Ratio

Share to Publication Bias

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 24086353
DOI: 10.1371/journal.pone.0074543
PMCID: PMC3781150

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.PMID 24086353Read ↗

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.Semantic proximity Read ↗

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.Semantic proximity Read ↗

FASLG polymorphism is associated with cancer risk.Semantic proximity Read ↗

The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.Semantic proximity Read ↗

Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.Semantic proximity Read ↗

FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.Semantic proximity Read ↗

Association of Fas -1377 G/A polymorphism with susceptibility to cancer.Semantic proximity Read ↗

Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Semantic proximity Read ↗

FASLG T844C polymorphism and susceptibility to breast cancer: a meta-analysis.Semantic proximity Read ↗

Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.